C2 Ceramide [3102-57-6]

Cat# HY-101180-5mg

Size : 5mg

Brand : MedChemExpress

Contact local distributor :


Phone : +1 850 650 7790

Description

C2 Ceramide (Ceramide 2) is the main lipid of the stratum corneum and a protein phosphatase 1 (PP1) activator. C2 Ceramide activates PP2A and ceramide-activated protein phosphatase (CAPP). C2 Ceramide induces cells differentiation, autophagy and apoptosis, inhibits mitochondrial respiratory chain complex III. C2 Ceramide is also a skin conditioning agent that protects the epidermal barrier from water loss[1][2][3][4][5].

IC50 & Target

Protein phosphatase 1[2]
PP2A[4]
Ceramide-activated protein phosphatase (CAPP)[4]
Apoptosis[1]
Mitochondrial respiratory chain complex III[1]

Cellular Effect
Cell Line Type Value Description References
CCRF-CEM IC50
31.6 μM
Compound: C2-ceramide
In vitro growth inhibitory effect in human T-cell acute leukemia cells CCRF-CEM
In vitro growth inhibitory effect in human T-cell acute leukemia cells CCRF-CEM
[PMID: 11689086]
FL5.12 IC50
33 μM
Compound: 9
Cytotoxicity against mouse FL5.12A cells after 48 hrs by DAPI staining-based flow cytometric analysis
Cytotoxicity against mouse FL5.12A cells after 48 hrs by DAPI staining-based flow cytometric analysis
[PMID: 27475534]
HCT-116 EC50
24.5 μM
Compound: 3, C2-ceramide
Cytotoxicity against HCT116 cells assessed as cell survival by SRB assay
Cytotoxicity against HCT116 cells assessed as cell survival by SRB assay
[PMID: 17561396]
HepG2 IC50
58 μM
Compound: 1a
Antiproliferative activity against human HepG2 cells after 24 hrs by Alamar blue assay
Antiproliferative activity against human HepG2 cells after 24 hrs by Alamar blue assay
[PMID: 25172146]
HL-60 IC50
26 μM
Compound: 1a
Antiproliferative activity against human HL60 cells after 24 hrs by Alamar blue assay
Antiproliferative activity against human HL60 cells after 24 hrs by Alamar blue assay
[PMID: 25172146]
HT-29 IC50
25.9 μM
Compound: C2-ceramide
Antiproliferative activity against human HT-29 cells measured after 72 hrs by sulforhodamine B assay
Antiproliferative activity against human HT-29 cells measured after 72 hrs by sulforhodamine B assay
[PMID: 33592537]
K562 EC50
35.1 μM
Compound: 3, C2-ceramide
Cytotoxicity against K562 cells assessed as cell survival by MTT assay
Cytotoxicity against K562 cells assessed as cell survival by MTT assay
[PMID: 17561396]
MCF7 IC50
45.41 μM
Compound: 1, C2 ceramide
Cytotoxicity against human MCF7 cells after 24 hrs by CellTiter-Blue assay
Cytotoxicity against human MCF7 cells after 24 hrs by CellTiter-Blue assay
[PMID: 19171486]
MDA-MB-231 IC50
35.37 μM
Compound: 1, C2 ceramide
Cytotoxicity against human MDA-MB-231 cells after 24 hrs by CellTiter-Blue assay
Cytotoxicity against human MDA-MB-231 cells after 24 hrs by CellTiter-Blue assay
[PMID: 19171486]
NCI-H358 EC50
19.6 μM
Compound: 3, C2-ceramide
Cytotoxicity against NCI-H358 cells assessed as cell survival by SRB assay
Cytotoxicity against NCI-H358 cells assessed as cell survival by SRB assay
[PMID: 17561396]
NHDF IC50
66.5 μM
Compound: 1, C2 ceramide
Cytotoxicity against NHDF after 24 hrs by CellTiter-Blue assay
Cytotoxicity against NHDF after 24 hrs by CellTiter-Blue assay
[PMID: 19171486]
PC-12 IC50
98 μM
Compound: 1a
Antiproliferative activity against rat PC12 cells after 24 hrs by Alamar blue assay
Antiproliferative activity against rat PC12 cells after 24 hrs by Alamar blue assay
[PMID: 25172146]
SK-BR-3 IC50
49.2 μM
Compound: 1, C2 ceramide
Cytotoxicity against human SKBR3 cells after 24 hrs by CellTiter-Blue assay
Cytotoxicity against human SKBR3 cells after 24 hrs by CellTiter-Blue assay
[PMID: 19171486]
SUP-T1 IC50
>200 μM
Compound: 2
Cytotoxicity against human SupT1 cells after 24 hrs by CellTiter-Blue assay
Cytotoxicity against human SupT1 cells after 24 hrs by CellTiter-Blue assay
[PMID: 19171486]
SUP-T1 IC50
41.44 μM
Compound: 1, C2 ceramide
Cytotoxicity against human SupT1 cells after 24 hrs by CellTiter-Blue assay
Cytotoxicity against human SupT1 cells after 24 hrs by CellTiter-Blue assay
[PMID: 19171486]
In Vitro

C2 Ceramide (5 nM-200 μM; 24 hours; primary mouse osteoblasts) treatment (≤500 nM) promots osteoblast viability, whilst concentrations ≥2 μM significantly reduces osteoblast viability in a dose- and time-dependent manner[1].
C2 Ceramide increases cytoplasmic histone-associated DNA fragments by 5.7- and 11.2-fold at 50 μM and 100 μM C2 Ceramide concentrations respectively in osteoblasts. At these higher concentrations, C2 Ceramide is a potent inducer of apoptosis in osteoblasts[1].
C2 Ceramide up-regulates mRNA expression of angiogenic genes in human dental pulp cells (HDPCs) and increases the migration and capillary tube formation of endothelial cells, whereas PP1 small interfering RNA shows opposite effects. Human dental pulp cells (HDPCs) increases levels of bone morphogenetic protein 2, phosphorylation of Smad 1/5/8, and mRNA expression of runt-related transcription factor 2 and osterix[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: Primary mouse osteoblasts
Concentration: 5 nM-200 µM
Incubation Time: 24 hours
Result: Murine osteoblasts demonstrated a dose-dependent increase in their survival rate when exposed to low concentrations of 5-500 n M. Increasing concentrations of 20-200µM caused a dose-dependent decrease in mitochondrial succinate dehydrogenase activity and osteoblast survival.
In Vivo

The PP1 activator C2 Ceramide increases alkaline phosphatase activity, mineralizes nodule formation, and mRNA expression of dentin matrix protein 1 and dentin sialophosphoprotein. In contrast, knockdown by PP1 small interfering RNA inhibits odontoblastic differentiation[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Molecular Weight

341.53

Formula

C20H39NO3

CAS No.
Appearance

Solid

Color

White to off-white

SMILES

O[C@H](/C=C/CCCCCCCCCCCCC)[C@H](CO)NC(C)=O

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

-20°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

Solvent & Solubility
In Vitro: 

Ethanol : 100 mg/mL (292.80 mM; Need ultrasonic)

DMSO : 50 mg/mL (146.40 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.9280 mL 14.6400 mL 29.2800 mL
5 mM 0.5856 mL 2.9280 mL 5.8560 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

  • Protocol 1

    Add each solvent one by one:  10% EtOH    90% Corn Oil

    Solubility: 5 mg/mL (14.64 mM); Clear solution; Need ultrasonic

    This protocol yields a clear solution of 5 mg/mL. If the continuous dosing period exceeds half a month, please choose this protocol carefully.

    Taking 1 mL working solution as an example, add 100 μL EtOH stock solution (50.0 mg/mL) to 900 μL Corn oil, and mix evenly.

  • Protocol 2

    Add each solvent one by one:  10% DMSO    90% Corn Oil

    Solubility: ≥ 2.5 mg/mL (7.32 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

Purity & Documentation
References